COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Poursuite de la croissance organique - Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%)
15/10/2024
Communiqué de presse Ecully, le 15 octobre 2024 –18h SPINEWAY Poursuite de la croissance organique Chiffre d’affaires à 9 mois 2024 de 9,1 M€ (+ 21%) En milliers d’euros 2024 2023 Variation en % CA 1 er trimestre 3 070 [...]
Trethera Announces Presentation at the Rare Neuroimmune Disorders Symposium Annual Meeting
15/10/2024
LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of [...]
EUROAPI closes the financing of its FOCUS-27 plan
15/10/2024
Press Release Paris - 15 October 2024 - EUROAPI today announces the closing of the refinanced Credit Revolving Facility (RCF) and the Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi, thus completing the [...]
EUROAPI clôt le financement de son plan FOCUS-27
15/10/2024
Communiqué de presse Paris - Le 15 octobre 2024 - EUROAPI annonce avoir clos le refinancement du contrat de crédit RCF (Credit Revolving Facility) et l’Obligation Hybride Perpétuelle Super Subordonnée souscrite par [...]
ARC Fertility Selected for BenefitsPRO’s 2024 Luminaries Awards for Humanizing Benefits
15/10/2024
CUPERTINO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility, family-forming and women’s and men’s health benefits for employers and their [...]
Adia Nutrition Inc. Takes Major Steps Forward: Signs LOI for First Clinic and Engages Legal Expertise for Licensing
15/10/2024
WINTER PARK, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Adia Nutrition (OTC Pink: ADIA) is proud to announce a groundbreaking initiative in the fight against Multiple Sclerosis (MS) with the signing of a Letter of Intent ( [...]
WellRithms Launches Comp42: Expands Suite of Payment Integrity Services for Workers' Compensation Bill Review, Combats Overpayment and Expedites Dispute Resolution
15/10/2024
PORTLAND, Ore., Oct. 15, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, demonstrates its market leadership with the launch of Comp42 , designed to revolutionize workers' compensation [...]
US Digestive Health Welcomes Seven New Physicians to Its Practice
15/10/2024
The physicians will support USDH’s expansion throughout Pennsylvania EXTON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the nation’s largest gastroenterology (GI) practices, today announced [...]
New AI Tool Helps Americans Get Immediate, Helpful Answers to HSA and Consumer-Directed Benefits Questions
15/10/2024
HSAnswers provides employees with quick access to benefits knowledge and helps benefits teams save time answering questions DRAPER, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity [...]
KFNCCC A Regional Leader in Pediatric Cancer Treatment
15/10/2024
RIYADH, Saudi Arabia, Oct. 15, 2024 (GLOBE NEWSWIRE) -- At the heart of advanced medical efforts in pediatric oncology in the Kingdom, King Fahad National Centre for Children's Cancer (KFNCCC), affiliated with King [...]
2025 Clover Health Medicare Advantage Benefits Demonstrate Commitment to New Jersey Seniors
15/10/2024
Company’s affordable, benefit-rich flagship PPO plans now have 4 Star rating FRANKLIN, Tenn., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Clover Health (Nasdaq: CLOV) (“Clover” or “the Company”) has announced the debut of its [...]
RTI International and Codetta Bio™ announce strategic collaboration to accelerate healthcare innovation
15/10/2024
Collaboration follows RTI’s equity investment in Codetta Bio RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2024 (GLOBE NEWSWIRE) -- RTI International, a nonprofit research organization, and Codetta Bio™, an emerging leader in [...]
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration
15/10/2024
Myriad’s MyRisk ® test is the first hereditary cancer test integrated into Flatiron’s OncoEMR ® SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in genetic testing and [...]
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder
15/10/2024
Study to Leverage Firefly’s BNA™ Technology for Biomarker Identification, with Potential Applications for Broader Neurological Research TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” [...]
Elematec Corporation Forms a Business Alliance with and Agrees to Make a Strategic Investment in MEDIROM Healthcare Technologies’ MOTHER Labs Subsidiary
15/10/2024
TOKYO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. has formed a capital and business alliance with Elematec Corporation ( [...]
Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing
15/10/2024
Collaboration to Enable Sequencing of Cellular Biopsies ZÜRICH, Switzerland and VIENNA, Austria , Oct. 15, 2024 (GLOBE NEWSWIRE) -- Cytosurge AG, a leader in single-cell manipulation, and Lexogen, a pioneer in RNA [...]
Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024
15/10/2024
Three abstracts accepted for poster presentations on ALG-000184 and ALG-055009 SOUTH SAN FRANCISCO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage [...]
Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholism's New Definition of Recovery
15/10/2024
AD04 Program Aligned with NIAAA's New Inclusion of Non-Abstinence Solutions, Validating Commercial and Government Market Potential GLEN ALLEN, Va., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: [...]
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia
15/10/2024
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 - - RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) Upon Marketing [...]

Pages